Pharmaceuticals - Top 5 Emerging Markets Industry Guide

Published by: Datamonitor

Published: Apr. 7, 2009 - 156 Pages

Table of Contents

CHAPTER 1 INTRODUCTION

1.1 What is this report about?

1.2 Who is the target reader?

1.3 How to use this report

1.4 Definitions

CHAPTER 2 TOP 5 EMERGING COUNTRIES PHARMACEUTICALS INDUSTRY OUTLOOK

CHAPTER 3 PHARMACEUTICALS IN BRAZIL

3.1 Market Overview

3.2 Market Value

3.3 Market Segmentation I

3.4 Market Segmentation II

3.5 Market Share

3.6 Five Forces Analysis

3.7 Leading Companies

3.8 Market Forecasts

3.9 Macroeconomic Indicators

CHAPTER 4 PHARMACEUTICALS IN CHINA

4.1 Market Overview

4.2 Market Value

4.3 Market Segmentation I

4.4 Market Segmentation II

4.5 Market Share

4.6 Five Forces Analysis

4.7 Leading Companies

4.8 Market Forecasts

4.9 Macroeconomic Indicators

CHAPTER 5 PHARMACEUTICALS IN INDIA

5.1 Market Overview

5.2 Market Value

5.3 Market Segmentation I

5.4 Market Segmentation II

5.5 Market Share

5.6 Five Forces Analysis

5.7 Leading Companies

5.8 Market Forecasts

5.9 Macroeconomic Indicators

CHAPTER 6 PHARMACEUTICALS IN MEXICO

6.1 Market Overview

6.2 Market Value

6.3 Market Segmentation I

6.4 Market Segmentation II

6.5 Market Share

6.6 Five Forces analysis

6.7 Leading Companies

6.8 Market Forecasts

6.9 Macroeconomic Indicators

CHAPTER 7 PHARMACEUTICALS IN SOUTH AFRICA

7.1 Market Overview

7.2 Market Value

7.3 Market Segmentation

7.4 Market Share

7.5 Five Forces Analysis

7.6 Leading Companies

7.7 Market Forecasts

7.8 Macroeconomic Indicators

CHAPTER 8 APPENDIX

8.1 Data Research Methodology

LIST OF TABLES

Table 1: Top 5 emerging countries Pharmaceuticals industry, revenue ($ bn) 2004-2013

Table 2: Top 5 emerging countries Pharmaceuticals industry, revenue ($bn) 2004-2008(e)

Table 3: Top 5 emerging countries Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013

Table 4: Brazil Pharmaceuticals Market Value: $ billion, 2004-2008

Table 5: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 6: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 7: Brazil Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 8: Key Facts: Novartis AG

Table 9: Key Financials: Novartis AG

Table 10: Key Facts: GlaxoSmithKline Plc

Table 11: Key Financials: GlaxoSmithKline Plc

Table 12: Key Facts: EMS Sigma Pharma Group

Table 13: Key Facts: Pfizer Inc

Table 14: Key Financials: Pfizer Inc

Table 15: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 16: Brazil Size of Population (million) , 2004-2008

Table 17: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 18: Brazil Inflation, 2004-2008

Table 19: Brazil Exchange Rate, 2004-2008

Table 20: China Pharmaceuticals Market Value: $ billion, 2004-2008(e)

Table 21: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 22: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 23: China Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 24: Key Facts: Jiangsu Yangtze River Pharmaceutical Group

Table 25: Key Facts: AstraZeneca PLC

Table 26: Key Financials: AstraZeneca PLC

Table 27: Key Facts: Pfizer Inc

Table 28: Key Financials: Pfizer Inc

Table 29: Key Facts: Roche Holding Ltd.

Table 30: Key Financials: Roche Holding Ltd.

Table 31: China Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 32: China Size of Population (million) , 2004-2008(e)

Table 33: China GDP (Constant 2000 Prices, $ billion), 2004-2008(e)

Table 34: China Inflation, 2004-2008(e)

Table 35: China Exchange Rate, 2004-2008(e)

Table 36: India Pharmaceuticals Market Value: $ billion, 2004-2008

Table 37: India Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 38: India Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 39: India Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 40: Key Facts: Cipla Ltd

Table 41: Key Financials: Cipla Ltd

Table 42: Key Facts: GlaxoSmithKline Plc

Table 43: Key Financials: GlaxoSmithKline Plc

Table 44: Key Facts: Ranbaxy Laboratories Limited

Table 45: Key Financials: Ranbaxy Laboratories Limited

Table 46: Key Facts: Nicholas Piramal India Limited

Table 47: India Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 48: India Size of Population (million) , 2004-2008

Table 49: India GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 50: India Inflation, 2004-2008

Table 51: India Exchange Rate, 2004-2008

Table 52: Mexico Pharmaceuticals Market Value: $ billion, 2004-2008

Table 53: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 54: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 55: Mexico Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 56: Key Facts: Pfizer Inc

Table 57: Key Financials: Pfizer Inc

Table 58: Key Facts: GlaxoSmithKline Plc

Table 59: Key Financials: GlaxoSmithKline Plc

Table 60: Key Facts: Eli Lilly and Company

Table 61: Key Financials: Eli Lilly and Company

Table 62: Key Facts: Sanofi-Aventis SA

Table 63: Key Financials: Sanofi-Aventis SA

Table 64: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 65: Mexico Size of Population (million) , 2004-2008

Table 66: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 67: Mexico Inflation, 2004-2008

Table 68: Mexico Exchange Rate, 2004-2008

Table 69: South Africa Pharmaceuticals Market Value: $ billion, 2004-2008

Table 70: South Africa Pharmaceuticals Market Segmentation: % Share, by Value, 2008(e)

Table 71: South Africa Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Table 72: Key Facts: Aspen Pharmacare Holdings Ltd

Table 73: Key Financials: Aspen Pharmacare Holdings Ltd

Table 74: Key Facts: GlaxoSmithKline Plc

Table 75: Key Financials: GlaxoSmithKline Plc

Table 76: Key Facts: Sanofi-Aventis SA

Table 77: Key Financials: Sanofi-Aventis SA

Table 78: Key Facts: Pfizer Inc

Table 79: Key Financials: Pfizer Inc

Table 80: South Africa Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Table 81: South Africa Size of Population (million) , 2004-2008

Table 82: South Africa GDP (Constant 2000 Prices, $ billion), 2004-2008

Table 83: South Africa Inflation, 2004-2008

Table 84: South Africa Exchange Rate, 2004-2008

LIST OF FIGURES

Figure 1: Top 5 emerging countries Pharmaceuticals industry, revenue ($ bn) 2004-2013

Figure 2: Top 5 emerging countries Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)

Figure 3: Top 5 emerging countries Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013

Figure 4: Brazil Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 5: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 6: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 7: Brazil Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 8: Forces Driving Competition in the Pharmaceutical Market in Brazil

Figure 9: Drivers of Buyer Power in the Pharmaceutical Market in Brazil

Figure 10: Drivers of Supplier Power in the Pharmaceutical Market in Brazil

Figure 11: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in Brazil

Figure 12: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in Brazil

Figure 13: Drivers of Degree of Rivalry in the Pharmaceutical Market in Brazil

Figure 14: Revenues & Profitability: Novartis AG

Figure 15: Revenues & Profitability: GlaxoSmithKline Plc

Figure 16: Revenues & Profitability: Pfizer Inc

Figure 17: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 18: China Pharmaceuticals Market Value: $ billion, 2004-2008(e)

Figure 19: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 20: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 21: China Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 22: Forces Driving Competition in the Pharmaceuticals Market in China

Figure 23: Drivers of Buyer Power in the Pharmaceuticals Market in China

Figure 24: Drivers of Supplier Power in the Pharmaceuticals Market in China

Figure 25: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China

Figure 26: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China

Figure 27: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China

Figure 28: Revenues & Profitability: AstraZeneca PLC

Figure 29: Revenues & Profitability: Pfizer Inc

Figure 30: Revenues & Profitability: Roche Holding Ltd.

Figure 31: China Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 32: India Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 33: India Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 34: India Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 35: India Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 36: Forces Driving Competition in the Pharmaceuticals Market in India

Figure 37: Drivers of Buyer Power in the Pharmaceuticals Market in India

Figure 38: Drivers of Supplier Power in the Pharmaceuticals Market in India

Figure 39: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in India

Figure 40: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in India

Figure 41: Drivers of Degree of Rivalry in the Pharmaceuticals Market in India

Figure 42: Revenues & Profitability: Cipla Ltd

Figure 43: Revenues & Profitability: GlaxoSmithKline Plc

Figure 44: Revenues & Profitability: Ranbaxy Laboratories Limited

Figure 45: India Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 46: Mexico Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 47: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 48: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 49: Mexico Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 50: Forces Driving Competition in the Pharmaceutical Market in Mexico

Figure 51: Drivers of Buyer Power in the Pharmaceutical Market in Mexico

Figure 52: Drivers of Supplier Power in the Pharmaceutical Market in Mexico

Figure 53: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in Mexico

Figure 54: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in Mexico

Figure 55: Drivers of Degree of Rivalry in the Pharmaceutical Market in Mexico

Figure 56: Revenues & Profitability: Pfizer Inc

Figure 57: Revenues & Profitability: GlaxoSmithKline Plc

Figure 58: Revenues & Profitability: Eli Lilly and Company

Figure 59: Revenues & Profitability: Sanofi-Aventis SA

Figure 60: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Figure 61: South Africa Pharmaceuticals Market Value: $ billion, 2004-2008

Figure 62: South Africa Pharmaceuticals Market Segmentation: % Share, by Value, 2008(e)

Figure 63: South Africa Pharmaceuticals Market Share: % Share, by Value, 2008(e)

Figure 64: Forces Driving Competition in the Pharmaceutical Market in South Africa

Figure 65: Drivers of Buyer Power in the Pharmaceutical Market in South Africa

Figure 66: Drivers of Supplier Power in the Pharmaceutical Market in South Africa

Figure 67: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in South Africa

Figure 68: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in South Africa

Figure 69: Drivers of Degree of Rivalry in the Pharmaceutical Market in South Africa

Figure 70: Revenues & Profitability: Aspen Pharmacare Holdings Ltd

Figure 71: Revenues & Profitability: GlaxoSmithKline Plc

Figure 72: Revenues & Profitability: Sanofi-Aventis SA

Figure 73: Revenues & Profitability: Pfizer Inc

Figure 74: South Africa Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Abstract

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
• Includes a five-year forecast of the industry

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.